Introduction and Objective:To evaluate the role of immediate uroflowmetry in patients of benign prostatic hyperplasia following transurethral resection of prostate.Methods:100 patients were included in our study who underwent TURP at our centre. Complete preoperative evaluation was done which included usg prostate, uroflometry and IPSS scoring. Uroflometry was done immediately at the time of catheter removal and after one and three month of surgery. Qmax, IPSS scoring were compared before and after TURP. Result: The mean patient age in study was 64.52 years. Mean Qmax, AFR and prostate weight were 8.30 ± 3.26 ml/sec, 4.82 ± 1.72ml/sec a nd 46.62 ± 31.10 gms respectively. Of the 100 patients, 75% patients were having immediate Qmax >15ml/sec and 25% were having <15 m l/sec. On comparing the mean value of different parameters between t hese two groups it was found that the difference between parameters were not statistically significant. Sensitivity and specificity of immediate uroflowmetry (Immediate Qmax ) were 91.3% and 61.3 % respectively. Positive predictive value of this test was 84% and the negative predictive value was 76%. Conclusion: Based on our experience, we conclude that immediate uroflowmetry after TURP can be used as a tool to predict the outcome of TURP up to three months after surgery with good accuracy but can these results be reciprocated on longer follow up need to be evaluated and can immediate uroflowmetry be used as a tool to differentiate those patients which are more likely to get re operated in the future need to be studied. For answering these questions further studies in the same direction with longer follow up period needed to be done.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.